| Title |
Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews
|
|---|---|
| Published in |
Drugs & Aging, May 2018
|
| DOI | 10.1007/s40266-018-0549-z |
| Pubmed ID | |
| Authors |
Tomas J. Welsh, Veronika van der Wardt, Grace Ojo, Adam L. Gordon, John R. F. Gladman |
X Demographics
The data shown below were collected from the profiles of 43 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 22 | 51% |
| United Kingdom | 2 | 5% |
| Chile | 1 | 2% |
| Cabo Verde | 1 | 2% |
| Colombia | 1 | 2% |
| Korea, Republic of | 1 | 2% |
| Netherlands | 1 | 2% |
| El Salvador | 1 | 2% |
| Venezuela, Bolivarian Republic of | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 12 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 35 | 81% |
| Practitioners (doctors, other healthcare professionals) | 8 | 19% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 137 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 14% |
| Student > Master | 19 | 14% |
| Student > Ph. D. Student | 15 | 11% |
| Student > Doctoral Student | 13 | 9% |
| Other | 8 | 6% |
| Other | 28 | 20% |
| Unknown | 35 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 26% |
| Pharmacology, Toxicology and Pharmaceutical Science | 17 | 12% |
| Nursing and Health Professions | 14 | 10% |
| Biochemistry, Genetics and Molecular Biology | 7 | 5% |
| Neuroscience | 4 | 3% |
| Other | 15 | 11% |
| Unknown | 44 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2020.
All research outputs
#1,659,171
of 25,732,188 outputs
Outputs from Drugs & Aging
#65
of 1,301 outputs
Outputs of similar age
#34,514
of 342,262 outputs
Outputs of similar age from Drugs & Aging
#2
of 14 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,301 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,262 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.